Top listeners:

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
  • cover play_arrow

    99.1 Mike FM The Hill Country's Strongest Radio Station

  • cover play_arrow

    94.3 Rev-FM The Rock of Texas | Where Texas Rocks

  • cover play_arrow

    103.7 The Buck Texas Country's Number 1 Country

  • play_arrow

    KERV 1230 AM

Health News

Monkeypox case trajectory could outpace current vaccine supply, vaccine expert says

todayAugust 3, 2022

share close

(NEW YORK) — The U.S. is currently in a race to have the necessary tools and medicines to stop the growing spread of monkeypox, and it may be an uphill battle, according to one vaccine expert.

Dr. Peter Hotez, the dean of the National School of Tropical Medicine at Baylor College of Medicine in Texas, spoke with ABC News Live Tuesday about the latest developments in the spread of the virus. Hotez said he’s concerned about the trajectory of new cases that are being reported throughout the country and the world.

As of Wednesday, 6,326 monkeypox cases have been confirmed in all states except Montana and Wyoming, according to the U.S. Centers for Disease Control and Prevention. No American has died from the virus, according to health officials. There have been 25,391 cases worldwide as of Wednesday, according to the CDC.

Hotez said the current monkeypox vaccine, JYNNEOS, is effective, but said the current supply may not be enough.

“It’s not dire yet, but the feeling is unless we work pretty quickly we could get there,” he told ABC News.

Monkeypox is spread through skin-to-skin contact, and although most known cases in the current outbreak are among people who identify as gay or bisexual, anyone can get it, Hotez said. As of Wednesday, five children have contracted the virus, the CDC said.

Hotez said the small supply of the vaccine, which was commissioned a decade ago, is the result of U.S. health officials letting a stockpile expire “inexplicably” and doing nothing to replenish it.

“When the outbreak began we only had a few thousands doses and we’re playing catchup ever since,” Hotez said.

The Food and Drug Administration announced last week that it had inspected and approved the manufacturing of 786,000 more doses of JYNNEOS for distribution in the U.S. and that more than a million doses will be available in the coming weeks.

On Tuesday, President Joe Biden announced FEMA administrator Robert Fenton would serve as the White House National Monkeypox Response Coordinator and Dr. Demetre Daskalakis would serve as the White House National Monkeypox Response Deputy Coordinator.

The pair will “will lead the Administration’s strategy and operations to combat the current monkeypox outbreak, including equitably increasing the availability of tests, vaccinations and treatments,” according to a statement from the White House.

Hotez said Biden’s appointees are qualified to lead the task and said one of the issues that they’re going to have to tackle is the vaccine supply. In addition, he said they will have to determine if there will be an increased call to use the antiviral drug tecovirimat, a.k.a. TPOXX, to treat patients while the country replenishes the vaccine supply.

“The problem is this: We don’t have the full armamentarium of tools to control it,” he said. “So we’re in a race trying to…accelerate the control tools, [so] that we have the diagnostics, the drugs and the vaccines versus that steep trajectory of cases.”

Copyright © 2022, ABC Audio. All rights reserved.


Written by: ABC News

Rate it

Previous post


Buck Country Music News

Cole Swindell shares the Tim McGraw duet he’ll never forget: “One of the coolest moments of my career”

ABC/Connie Chornuk For Cole Swindell, there’s not much that can top a live duet with Tim McGraw. That’s exactly what happened last week at Michigan’s Faster Horses Festival: Tim and Cole got to share the stage, performing a live rendition of Tim’s classic “I Like It, I Love It” as a packed crowd of fans roared along with them. Cole shared a close-up video of the moment on Instagram this […]

todayAugust 3, 2022

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *